A Trial of IDN-6556 in Post Orthotopic Liver Transplant for Chronic HCV
Status:
Completed
Trial end date:
2018-03-09
Target enrollment:
Participant gender:
Summary
This is a double-blind, multicenter study involving patients with chronic HCV infection who
had a liver transplantation; developed HCV-related liver fibrosis and/or incomplete
cirrhosis; achieved a sustained virologic response (SVR) following anti-HCV therapy; but
still have fibrosis and/or incomplete cirrhosis on liver biopsy to see if treatment with
IDN-6556 is better than placebo in reversing or stopping the progression of the damage to the
new liver caused by HCV.